Transitioning from Aflibercept to Biosimilar Ranibizumab in Diabetic Macular Edema (DME): (The TRANSFORM-DME Trial) a Multicenter Observational Study

Transitioning from Aflibercept to Biosimilar Ranibizumab in Diabetic Macular Edema (DME): (The TRANSFORM-DME Trial) a Multicenter Observational Study

Debdulal Chakraborty,1 Tushar Kanti Sinha,1 Aniruddha Maiti,2 Subhendu Kumar Boral,1 Arnab Das,1 Soumen Mondal,1 Krishnendu Nandi,3 Ranabir Bhattacharya1 1Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, West Bengal, India; 2Department of Vitreoretinal Services, Global Eye Hospita...

Full description

Saved in:
Bibliographic Details
Main Authors: Chakraborty D, Sinha TK, Maiti A, Boral SK, Das A, Mondal S, Nandi K, Bhattacharya R
Format: Article
Language:English
Published: Dove Medical Press 2024-11-01
Series:Clinical Ophthalmology
Subjects:
diabetic macular edema
anti vegf
aflibercept
biosimilar ranibizumab
Online Access:https://www.dovepress.com/transitioning-from-aflibercept-to-biosimilar-ranibizumab-in-diabetic-m-peer-reviewed-fulltext-article-OPTH
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/transitioning-from-aflibercept-to-biosimilar-ranibizumab-in-diabetic-m-peer-reviewed-fulltext-article-OPTH

Similar Items